GENEVA ADDISON: Open Payments
NPI 1649914680 · DARLINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 42 payments from 16 companies in 2025. Trend: 2023 $284 · 2024 $871 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $265 |
| Amgen Inc. | 8 | $163 |
| Insulet Corporation | 1 | $150 |
| ABBVIE INC. | 4 | $97 |
| Corcept Therapeutics | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| Exact Sciences Corporation | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: Ozempic, Omnipod, OTEZLA, Wegovy, MAVYRET, Korlym, NEXLETOL, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
